Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

6,769 total articles

American Battery Technology Company Announces Record Breaking Revenue and First-Ever Positive Gross Margin in Third Quarter Fiscal 2026 Financial Results

American Battery Technology Company Announces Record Breaking Revenue and First-Ever Positive Gross Margin in Third Quarter Fiscal 2026 Financial Results

American Battery Technology Company (NASDAQ: ABAT) announced its third quarter fiscal 2026 results, reporting a 64% quarter-over-quarter revenue increase to $7.8 million and its first-ever positive gross margin of $0.7 million. The growth was driven by increased throughput and operational efficiency at its Nevada recycling facility, as well as prog…

MIND CTI Reports First Quarter 2026 Results

MIND CTI Reports First Quarter 2026 Results

MIND C.T.I. Ltd. reported first quarter 2026 revenues of $5.1 million, slightly above the prior year, with net income rising to $0.9 million due to prior year credit loss adjustments. Despite steady revenues, the company faces market and pricing pressures, including a major customer’s non-renewal notice effective March 2027 that may adversely impac…

Lemonade Launches Award-Winning Renters Insurance in Delaware

Lemonade Launches Award-Winning Renters Insurance in Delaware

Lemonade, a technology-driven insurance company listed on the NYSE as LMND, announced the launch of its renters insurance product in Delaware. This expansion further extends Lemonade's innovative, affordable, and digital renters coverage across the U.S., offering policies starting at $5 per month with convenient app-based management and instant cla…

Acoramidis Continues to Demonstrate Disease-Modifying Effects in ATTR-CM, Reducing sTTR Variability and Outpatient Worsening Heart Failure

Acoramidis Continues to Demonstrate Disease-Modifying Effects in ATTR-CM, Reducing sTTR Variability and Outpatient Worsening Heart Failure

BridgeBio Pharma presented new Phase 3 data for its drug acoramidis demonstrating early and sustained reduction in serum transthyretin variability, outpatient worsening heart failure, and cardiovascular hospitalizations in patients with transthyretin amyloid cardiomyopathy (ATTR-CM). The data show acoramidis improves survival and functional outcome…

Biodesix Announces ATS 2026 Presentations Providing Real-World Clinical Evidence and Healthcare System Economic Value for Nodify Lung® Testing Strategy

Biodesix Announces ATS 2026 Presentations Providing Real-World Clinical Evidence and Healthcare System Economic Value for Nodify Lung® Testing Strategy

Biodesix, Inc. announced presentations at the American Thoracic Society 2026 Annual Meeting showcasing real-world clinical data and healthcare system economic value of its Nodify Lung® blood-based testing for lung nodule risk stratification. The data highlights improvements in lung cancer detection and patient outcomes, supported by academic and co…

RenX Enterprises Corp. Issues Letter to Shareholders

RenX Enterprises Corp. Issues Letter to Shareholders

RenX Enterprises Corp. outlines strategic progress including integration of Resource Group US Holdings and upgrades to its biomass recycling operations. With growing geopolitical disruption causing input price inflation and import dependencies in agriculture, RenX positions its locally sourced, engineered soils as a strategic alternative. The compa…

WORK Medical Collaborates with Novabioplus to Unlock Biological Data Value with AI, Advancing the “BioToken” Assetization Model

WORK Medical Collaborates with Novabioplus to Unlock Biological Data Value with AI, Advancing the “BioToken” Assetization Model

WORK Medical Technology Group LTD announced a strategic cooperation agreement with Shanghai Novabioplus Biotechnology Co., Ltd. to jointly develop AI-driven intelligent medical models focused on protein antibody therapeutics. The collaboration includes four major AI+ projects targeting biomolecular design and functional simulation. They aim to crea…

Ernexa Therapeutics Releases Virtual Investor KOL Connect Segment Highlighting Ovarian Cancer Landscape and Lead Candidate ERNA-101

Ernexa Therapeutics Releases Virtual Investor KOL Connect Segment Highlighting Ovarian Cancer Landscape and Lead Candidate ERNA-101

Ernexa Therapeutics released a Virtual Investor KOL Connect segment featuring insights from its Chief Scientific Officer on the complexities of ovarian cancer and the potential for their lead cell therapy candidate ERNA-101 to address existing treatment limitations. The company also announced participation in an upcoming Virtual Investor Closing Be…

The Boston Beer Company Lights Up Ready-To-Drink Market with All-New 15% Alc. LYTT® Electric Coolers™

The Boston Beer Company Lights Up Ready-To-Drink Market with All-New 15% Alc. LYTT® Electric Coolers™

The Boston Beer Company introduces LYTT® Electric Coolers, a new line of single-serve, 15% alcohol-by-volume ready-to-drink beverages packaged in patent-pending, glow-in-the-dark lightbulb-shaped containers. Launching in select U.S. markets in mid-2026, this product aims to capture a share of the growing high-alcohol ready-to-drink market with recy…

Longeveron Announces Independent Data Monitoring Committee Positive Review and Recommendation to Complete Phase 2b Stem Cell Therapy Clinical Trial in Hypoplastic Left Heart Syndrome (HLHS)

Longeveron Announces Independent Data Monitoring Committee Positive Review and Recommendation to Complete Phase 2b Stem Cell Therapy Clinical Trial in Hypoplastic Left Heart Syndrome (HLHS)

Longeveron Inc. announced that the independent Data Monitoring Committee (DMC) conducted a final safety review of the fully enrolled Phase 2b clinical trial (ELPIS II) evaluating laromestrocel as adjunct therapy for Hypoplastic Left Heart Syndrome (HLHS). The DMC found no new safety concerns, approved continuation to completion, and top-line result…

HiFi Solves Sub-fertility Consortium in Asia Pacific Reports First Major Study Using HiFi Long-Read Sequencing to Investigate Unexplained Subfertility and Recurrent Pregnancy Loss

HiFi Solves Sub-fertility Consortium in Asia Pacific Reports First Major Study Using HiFi Long-Read Sequencing to Investigate Unexplained Subfertility and Recurrent Pregnancy Loss

PacBio announced the first major study from the HiFi Solves Sub-fertility Consortium in Asia Pacific, showcasing the use of their HiFi long-read whole genome sequencing to analyze unexplained subfertility and recurrent pregnancy loss across multiple institutions. The study demonstrated that HiFi sequencing can provide a comprehensive genetic view i…

Brookfield to Invest $500 Million in Strategic Partnership with OpenAI

Brookfield to Invest $500 Million in Strategic Partnership with OpenAI

Brookfield Asset Management has agreed to invest $500 million in The OpenAI Deployment Company, a joint venture with OpenAI and other investors aimed at accelerating large-scale enterprise AI deployment. Brookfield sees this partnership as a key growth driver to leverage AI technologies across its global portfolio, focusing on improving productivit…

Telos Corporation Announces First Quarter 2026 Earnings

Telos Corporation Announces First Quarter 2026 Earnings

Telos Corporation, a leading provider of cybersecurity and enterprise security solutions, has posted its financial results for the first quarter of 2026 and scheduled a live webcast to discuss the results. The company serves the U.S. federal government and global enterprises with advanced cyber governance, identity, biometric, and secure communicat…

Airship AI Reports First Quarter 2026 Financial Results

Airship AI Reports First Quarter 2026 Financial Results

Airship AI Holdings, Inc. announced its Q1 2026 financial results showing a 15% increase in net revenues to $6.3 million and a gross margin of 50%, driven by increased sales of proprietary hardware and software. Despite a net loss of $721,000 impacted by stock-based compensation and noncash expenses, the company maintained positive operating cash f…